The Spectranetics Corporation has announced its results for the frist quarter FY-2015. The Results shows the following:- Annual revenue up by 45% at $57.4 million, Quarterly Net Loss or EPS went down to -$0.65 from -$0.14. View the full earnings release here.
Spectranetics Revenues Up $SPAN $XHS Read More »
Abbott Laboratories has announced its Financial results for first Quarter of FY-2015. The Results shows the following:- Total revenues downs by -6.6% at $4897 Million, EPS was $2.10 Projected EPS was $1.33. View the full earnings release here.
Abbott Earnings Rise $ABT $XHS Read More »
Vascular Solutions yesterday has announced its 1st quarter results for FY-2015. on the base of which the firm has raised its guidance for 2nd Quarter FY-2015. The results shows 15.7% rise in Revenues and -25% fall in EPS. View the full earnings release here.
Vascular Solutions Guidance Raised $VASC $XHS Read More »
NeuroMetrix Inc., has announced its Q1 2015 Financial Results. The results shows the following:- Quarterly Revenue were $1.3 Million Stable Y/Y, Net Loss $0.25 from $0.21 last year. View the full earnings release here.
NeuroMetrix Earnings Down $NURO $XHS Read More »
Pfizer has annouced that its phase 3 study trials of treatment of inotuzumab ozogamicin met its first primary endpoint of demonstrating a higher complete hematologic remission rate in adult patients with relapsed or refractory CD22-positive acute lymphoblastic leukemia (ALL) compared to that achieved with standard of care chemotherapy. The above success conjugates a new drug for
Pfizer Leukmia Drug Success $PFE $XHS Read More »
